| In vitro and in vivo evaluation of biologically synthesized silver nanoparticles for topical applications: effect of surface coating and loading into hydrogels AI Mekkawy, MA El-Mokhtar, NA Nafady, N Yousef, MA Hamad, ... International journal of nanomedicine, 759-777, 2017 | 159 | 2017 |
| Formulation and in vitro evaluation of fluconazole topical gels A Mekkawy, M Fathy, S El-Shanawany British Journal of Pharmaceutical Research 3 (3), 293-313, 2013 | 44 | 2013 |
| New 1, 2, 3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization HHH Mohammed, AA Abd El-Hafeez, K Ebeid, AI Mekkawy, ... Journal of enzyme inhibition and medicinal chemistry 37 (1), 1346-1363, 2022 | 21 | 2022 |
| Combinatorial therapy of letrozole-and quercetin-loaded spanlastics for enhanced cytotoxicity against MCF-7 breast cancer cells AI Mekkawy, NE Eleraky, GM Soliman, MG Elnaggar, MG Elnaggar Pharmaceutics 14 (8), 1727, 2022 | 20 | 2022 |
| Chitosan nanoparticles for meloxicam ocular delivery: development, in vitro characterization, and in vivo evaluation in a rabbit eye model HB Mohamed, MA Attia Shafie, AI Mekkawy Pharmaceutics 14 (5), 893, 2022 | 15 | 2022 |
| Study of fluconazole release from o/w cream and water soluble ointment bases AIAA Mekkawy, M Fathy, S El-Shanawany British Journal of Pharmaceutical Research 3 (4), 686-696, 2013 | 15 | 2013 |
| Paclitaxel anticancer activity is enhanced by the MEK 1/2 inhibitor PD98059 in vitro and by PD98059-loaded nanoparticles in BRAFV600E melanoma-bearing mice AI Mekkawy, YW Naguib, SO Alhaj-Suliman, EI Wafa, K Ebeid, T Acri, ... International journal of pharmaceutics 606, 120876, 2021 | 12 | 2021 |
| An injectable microparticle formulation provides long-term inhibition of hypothalamic ERK1/2 activity and sympathetic excitation in rats with heart failure YW Naguib, Y Yu, SG Wei, A Morris, BE Givens, AI Mekkawy, RM Weiss, ... Molecular pharmaceutics 17 (9), 3643-3648, 2020 | 8 | 2020 |
| Silver nanoparticles-loaded hydrogels, a potential treatment for resistant bacterial infection and wound healing: A review AI Mekkawy, MA El-Mokhtar, SM El-Shanawany, EH Ibrahim J. Pharm. Res. Int 14, 1-19, 2016 | 8 | 2016 |
| The MEK 1/2 inhibitor PD98059 exhibits synergistic anti-endometrial cancer activity with paclitaxel in vitro and enhanced tissue distribution in vivo when formulated into PAMAM … K Wiwatchaitawee, AI Mekkawy, JC Quarterman, YW Naguib, K Ebeid, ... Drug delivery and translational research, 1-13, 2021 | 5 | 2021 |
| Evaluation of Different Surface Coating Agents for Selenium Nanoparticles: Enhanced Anti-Inflammatory Activity and Drug Loading Capacity AI Mekkawy, M Fathy, HB Mohamed Drug Design, Development and Therapy, 1811-1825, 2023 | 2 | 2023 |
| Compositions comprising molecules for cystic fibrosis treatment AK Salem, DA Stoltz, MJ Welsh, S Ernst, YW Naguib, DS NAkhla, ... US Patent App. 18/256,593, 2024 | | 2024 |
| A green chemistry approach for preparation of metronidazole-zinc (ІІ) complexes: In vitro characterization, antimicrobial activity and promising cytotoxicity HB Mohamed, AI Mekkawy, AZ Mahmoud, D Fathalla, EA Fouad Journal of Drug Delivery Science and Technology, 105616, 2024 | | 2024 |
| Injectable long-acting ivacaftor-loaded poly (lactide-co-glycolide) microparticle formulations for the treatment of cystic fibrosis: In vitro characterization and in vivo … DS Nakhla, AI Mekkawy, YW Naguib, AD Silva, D Gao, JA Kim, ... International journal of pharmaceutics 650, 123693, 2024 | | 2024 |
| Development and optimization of albendazole nanosuspension as local adjuvant therapy for treatment of Enterobiasis A Mekkawy, G Fetih, M El-Badry, A Allam Bulletin of Pharmaceutical Sciences. Assiut, 2020 | | 2020 |
